article thumbnail

Drug side effects should be easier to understand

World of DTC Marketing

” Drug facts boxes are needed, but the FDA disagrees. According to the AMA one of the key reasons for non-adherence is that patients may be frightened of potential side effects. From seeing those side effects experienced by someone else, it may have led them to believe the medication caused those problems.

article thumbnail

A realistic view of healthcare in 2022

World of DTC Marketing

Yes, there will be changes in healthcare in the coming years but put away the thoughts that telehealth and wearable devices will revolutionize healthcare. Semaglutide’s study results were enough to warrant plenty of hype for obesity treatment despite the list of potential nasty side effects.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The FDA and Aduhelm: WTF?

World of DTC Marketing

One agency FDA adviser, resigning from his committee post in protest, called it “probably the worst drug approval decision in recent U.S. Source: STAT News Our healthcare system can’t continue to support drugs that don’t have good clinical outcomes behind them. I, therefore, find the FDA’s decision to be puzzling.

FDA 218
article thumbnail

What DTC marketers can learn from people who refuse a COVID vaccination

World of DTC Marketing

Concerns about safety, fear of unknown side effects, and misinformation about COVID-19 are some reasons why people may not accept the vaccine. The media stories about the FDA. DTC marketers need to be more forthcoming when it comes to drug trials and side effects. So how should DTC marketers view this?

Marketing 279
article thumbnail

Healthcare Watch October 2023

PM360

Of the eight FDA-approved weight loss drugs on the market, these two are making waves for doctors who believe they represent “a new era for weight loss medications,” and “changing options and giving hope.” “They are effective but too expensive for the majority of patients, even with insurance coverage,” said one primary care physician (PCP).

article thumbnail

FDA backs pharmacist prescribing of Paxlovid for COVID

pharmaphorum

Some patients with COVID-19 will be able to get easier access to Pfizer’s oral antiviral therapy Paxlovid, after the FDA ruled that pharmacists would be able to prescribe the drug. I've worked, including through Test to Treat, to expand access to Paxlovid, a pill shown to curb the worst effects of COVID-19. It made $1.5

FDA 93
article thumbnail

Biogen: It’s a cruel business world

World of DTC Marketing

In trying to save the product, Biogen’s reputation was trashed by FDA advisors, HCPs, and the healthcare media. 2wo: The competition’s MS drugs were better – The MS market is lucrative, and competitors launched products that were better than Biogen’s with fewer side effects discussed by the MS community online.